Delving into the Latest Updates on Hallux, Inc. with Synapse

概览

关联

2

项与 Hallux, Inc. 相关的临床试验

NCT05135910

/ Active, not recruiting临床2期

An Open Label Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Hallux Terbinafine Subungual Gel Administered to the Toenail Bed of Patients With Distal-Lateral Subungual Onychomycosis

The key objective is to establish the efficacy, safety, tolerability, and pharmacokinetics of investigational drug Hallux Terbinafine Subungual Gel (HSG) administered over 44 weeks to patients with distal-lateral subungual onychomycosis (DLSO).

开始日期2022-01-13

申办/合作机构

Hallux, Inc.

NCT02798380

/ Completed临床2期

An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail

The purpose of this study is to assess the efficacy, safety and tolerability of HTS-519 Inserts in the treatment of mild to moderate toenail fungus disease of the big toenail.

开始日期2016-07-01

申办/合作机构

Hallux, Inc.

100 项与 Hallux, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Hallux, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Hallux, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Hallux, Inc. 相关的转化医学

登录后查看更多信息